Communicating a drug alert M. C. J. M. SturkenboomL. T. W. de Jong-van den BergH. Wesseling Special Article Pages: 125 - 132
Safety and efficacy of lifibrol upon four-week administration to patients with primary hypercholesterolaemia P. SchwandtR. ElsäßerK. Seibel Clinical Trials Pages: 133 - 138
Suppression of respiratory burst of polymorphonuclear leukocytes by Azelastine hydrochloride (Azeptin) E. UetaT. OsakiY. Nomura Pharmacodynamics Pages: 139 - 145
Angiotensin converting enzyme inhibition does not affect response to exogenous angiotensin II in the forearm of mild-moderate hypertensive patients D. LyonsJ. WebsterN. Benjamin Pharmacodynamics Pages: 147 - 150
Characteristics of plasma protein binding of tacrine hydrochloride: a new drug for Alzheimer's disease P. M. MäkeläC. A. TrumanC. J. C. Roberts Pharmacokinetics and Disposition Pages: 151 - 155
Pharmacokinetics of torasemide and its metabolites in end-stage renal disease B. K. KrämerA. SchwabG. A. Müller Pharmacokinetics and Disposition Pages: 157 - 159
The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites M. C. RouanJ. B. LecaillonJ. C. Aldigier Pharmacokinetics and Disposition Pages: 161 - 167
Cholesterol malabsorption caused by sitostanol ester feeding and neomycin in pravastatin-treated hypercholesterolaemic patients H. Vanhanen Pharmacokinetics and Disposition Pages: 169 - 176
Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB) L. F. LaceyN. M. FrazerO. N. Keene Pharmacokinetics and Disposition Pages: 177 - 180
Pharmacokinetics of intravenous omeprazole in children E. Jacqz-AigrainJ. AndreV. Baudouin Original Pages: 181 - 185
Pharmacokinetic analysis of sparse in vivo NMR spectroscopy data using relative parameters and the population approach R. E. PortH. -P. SchlemmerP. Bachert Pharmacokinetics and Disposition Pages: 187 - 193
Using ofloxacin as a time marker in hair analysis for monitoring the dosage history of haloperidol M. NakanoH. SatoM. Nishimoto Pharmacokinetics and Disposition Pages: 195 - 202
Cost evaluation of a new IV device in an Israeli hospital A. Lustig Pharmacokinetics and Disposition Pages: 203 - 206
Interaction between FK 506 and clarithromycin in a renal transplant patient K. WolterK. WagnerE. Fritschka Letter to the Editor Pages: 207 - 208
Glucuronidation clearance of 8-hydroxyclomipramine in relation to sparteine and mephenytoin phenotype K. Kramer NielsenK. BrøsenM. G. J. Hansen Letter to the Editor Pages: 209 - 210
